Arcturus Therapeutics Holdings Inc. (ARCT) vs Ocugen, Inc. (OCGN)
A side-by-side comparison of Arcturus Therapeutics Holdings Inc. and Ocugen, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ARCT
Arcturus Therapeutics Holdings Inc.
$13.27HealthcareDelayed quote: Oct 6, 2026, 2:20 PM EDT
OCGN
Ocugen, Inc.
$1.06HealthcareDelayed quote: Oct 6, 2026, 2:19 PM EDT
Total return — ARCT vs OCGN
growth of $100 · dividends reinvested · last 10yARCT -18.2% (-2.0%/yr)OCGN -99.4% (-40.4%/yr)ARCT compounded faster over this window
Log scale — wide-divergence pair
ARCT OCGN
ARCT vs OCGN: by the numbers
- •ARCT is the larger company ($377M vs $359M market cap).
- •Both run net losses; ARCT's is the smaller (-391.90% vs -1786.27% net margin).
Metrics side by side
Valuation
| Metric | ARCT | OCGN |
|---|---|---|
| P/S ratio | 15.85 | 78.48 |
| P/B ratio | 2.20 | N/A |
Profitability
| Metric | ARCT | OCGN |
|---|---|---|
| Gross margin | 95.50% | 45.86% |
| Operating margin | -111.51% | -1425.70% |
| Net margin | -391.90% | -1786.27% |
| ROE | -54.29% | N/A |
| ROIC | -54.07% | -93.74% |
Growth (annualized)
| Metric | ARCT | OCGN |
|---|---|---|
| Revenue CAGR (5Y) | 22.30% | N/A |
| Total return CAGR (5Y) | -18.73% | -31.57% |
Frequently asked
- How have ARCT and OCGN total returns compared?
- Over the past 10 years, ARCT delivered -2.54% and OCGN delivered -40.73% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Arcturus Therapeutics ROEOcugen ROEArcturus Therapeutics operating marginOcugen operating marginArcturus Therapeutics revenue growthOcugen revenue growthArcturus Therapeutics free cash flowOcugen free cash flow
Arcturus Therapeutics & Ocugen appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.